Clinical Trial Update: Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of apixaban to prevent portal hypertension complications in cirrhosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis
• Esophageal Varices
• Gastric Varices
• Hepatic Encephalopathy
• Portal Hypertension
• Portal Vein Thrombosis

Drugs mentioned

• Apixaban (apixaban)

Snippet

Sponsor: Asian Institute Of Medical Sciences | Conditions: Cirrhosis, Esophageal and Gastric Varices | Phase 4 | Status: RECRUITING